Before you sell to, join or invest in VOLITIONRX LTD
MentionFox check on VOLITIONRX LTD: no red flags found in 3 sources (checked 4 November 2026). mentionfox.com/c/funding/volitionrx-ltd-form-d-25000001
Check VOLITIONRX LTD before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about VOLITIONRX LTD?
Based on the records MentionFox holds for this company. No flag is not a clearance.
VOLITIONRX LTD filed an amended Form D with the Securities and Exchange Commission on 2025-05-30.
VOLITIONRX LTD filed an amended Form D notice of an exempt securities offering with the SEC on May 30, 2025. The filing reports $22.65M sold. Its industry group is Biotechnology. It names Cameron Reynolds (Executive Officer, Director), Terig Hughes (Executive Officer), Rodney Rootsaert (Executive Officer) (SEC Form D/A, May 30, 2025).
Is this your company?
Sell to companies like VOLITIONRX LTD? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-05-30 · the record
Pitching, partnering or investing alongside them? See who really runs and owns VOLITIONRX LTD.
Free to see. No signup.
More on the people and the money behind VOLITIONRX LTD, from the filings we hold.
Biotechnology raises by companies based in Nevada, filed in May 2025, largest first.
Get an email when VOLITIONRX LTD files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when VOLITIONRX LTD raises, hires or launches. No email unless you switch it on.
Watch VOLITIONRX LTD →Get the full cited report on VOLITIONRX LTD
What the filing shows about VOLITIONRX LTD
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on VOLITIONRX LTD: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives VOLITIONRX LTD's address as 1489 West Warm Springs Road, Suite 110, Henderson, NV 89014.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for VOLITIONRX LTD →
Amended on 2026-01-28: the offering size changed from $16,250,000 to $22,650,000; the amount sold changed from $16,250,000 to $22,650,000. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
VOLITIONRX LTD is a registered filer with the SEC (CIK 93314) and has filed since 2024-03-26. 3 filings are on record, the latest on 2026-01-28.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
VOLITIONRX LTD's Form D of 2025-05-30 names Cameron Reynolds, Terig Hughes, Rodney Rootsaert and 14 more as its officers, directors or promoters.
Its new offerings report $16.35M sold across 2 offerings, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 766 filings in Biotechnology, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
Volition is a multi-national epigenetics company focused on advancing the science of epigenetics. Volition is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well…
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Cameron Reynolds is named as Executive Officer and Director on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Terig Hughes is named as Executive Officer on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Rodney Rootsaert is named as Executive Officer on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Louise Batchelor is named as Executive Officer on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Salvatore Butera is named as Executive Officer on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Gael Forterre is named as Executive Officer on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Jasmine Kway is named as Executive Officer on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Jacob Micallef is named as Executive Officer on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Gaetan Michel is named as Executive Officer on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Nicholas Plummer is named as Executive Officer on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Alan Colman is named as Director on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Mickie Henshall is named as Director on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Guy Innes is named as Director on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Kim Nguyen is named as Director on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Phillip Barnes is named as Director on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Timothy Still is named as Director on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
Ethel Rubin is named as Director on the Form D that VOLITIONRX LTD filed with the SEC on 30 May 2025, one of 17 people that filing names.
17 people named on the filing — 10 holding an executive role and 7 as directors only.
Named as of the 2025-05-30 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
Of the 17 names on this filing, 12 are drawn here to keep the picture readable. The People tab lists them all.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about VOLITIONRX LTD
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on VOLITIONRX LTD: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on VOLITIONRX LTD covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist VOLITIONRX LTDYou get an alert in MentionFox the next time this company shows up.
If you're behind VOLITIONRX LTD: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-02 (ir.volition.com).
Each opens in a new tab, filled in for VOLITIONRX LTD. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Las Vegas
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/volitionrx-ltd-form-d-25000001